Kauker M L
J Pharmacol Exp Ther. 1977 Jan;200(1):81-7.
The renal effects of a new, substituted indanyloxyacetic acid diuretic agent were evaluated in 16 anesthetized rats using micropuncture and clearance techniques. Glomerular filtration rate, mean arterial pressure and hematocrit remained unchanged. Urine flow increased 13 times after i.v. administration of 50 mg/kg b.wt. of the diuretic. Sodium excretion increased from 0.4 +/- 0.05% of the amount filtered to 6.62+/-0.87%. Potassium urine/plasma concentration ratio declined 6-fold while potassium excretion nearly doubled. Proximal tubular reabsorption was not altered significantly by this indanone diuretic. Reabsorption was markedly inhibited between late proximal and early distal micropuncture sites, that is, in the loop of Henle. The diuretic did not appear to interfere with normal distal tubular function. In the collecting tubules, reabsorption was markedly reduced from 41+/-0.2 mul/min/100 g b.wt. to 26+/-5 (with P less than .005). This new indanone compound appears to be a potent, specific natriuretic diuretic agent which inhibits tubular reabsorption primarily in the loop of Henle and collecting tubules, that is, in distal nephron segments located deep within the kidney. It produces a somewhat delayed but prolonged diuresis in the rat.
使用微穿刺和清除技术,在16只麻醉大鼠中评估了一种新型取代茚满氧基乙酸利尿剂的肾脏效应。肾小球滤过率、平均动脉压和血细胞比容保持不变。静脉注射50mg/kg体重的利尿剂后,尿流量增加了13倍。钠排泄从滤过量的0.4±0.05%增加到6.62±0.87%。钾尿/血浆浓度比值下降了6倍,而钾排泄几乎增加了一倍。这种茚满酮利尿剂对近端肾小管重吸收没有显著改变。在近端肾小管晚期和远端肾小管早期微穿刺部位之间,即髓袢中,重吸收受到明显抑制。该利尿剂似乎不干扰远端肾小管的正常功能。在集合管中,重吸收从41±0.2μl/min/100g体重显著降低到26±5(P<0.005)。这种新型茚满酮化合物似乎是一种强效、特异性的利钠利尿剂,主要抑制髓袢和集合管中的肾小管重吸收,即位于肾脏深部的远端肾单位节段。它在大鼠中产生了一定延迟但持续时间较长的利尿作用。